Multifactorial approaches to enhance maturation of human iPSC-derived cardiomyocytes

被引:3
|
作者
Kistamas, Kornel [1 ]
Muller, Anna [1 ]
Muenthaisong, Suchitra [1 ]
Lamberto, Federica [1 ,2 ]
Zana, Melinda [1 ]
Dulac, Martin [3 ]
Leal, Filipa [4 ]
Maziz, Ali [5 ]
Costa, Pedro [4 ]
Bernotiene, Eiva [6 ]
Bergaud, Christian [5 ]
Dinnyes, Andras [1 ,7 ]
机构
[1] BioTalentum Ltd, Aulich Laj Str 26, H-2100 Godollo, Hungary
[2] Hungarian Univ Agr & Life Sci, Inst Physiol & Anim Nutr, Dept Physiol & Anim Hlth, Pater Karoly Str 1, H-2100 Godollo, Hungary
[3] OSPIN GmbH, Helmholtzstr 9, D-10587 Berlin, Germany
[4] Biofab Lda, Rua Alfredo Allen 455, P-4200135 Porto, Portugal
[5] French Natl Ctr Sci Res LAAS CNRS, Lab Anal & Architecture Syst, 7 Ave Colonel Roche, F-31400 Toulouse, France
[6] State Res Inst Ctr Innovat Med, Dept Regenerat Med, Santariskiu G 5, LT-08406 Vilnius, Lithuania
[7] Univ Szeged, Dept Cell Biol & Mol Med, Dugon Sq 13, H-6720 Szeged, Hungary
基金
欧盟地平线“2020”;
关键词
hiPSC-CM; Human induced pluripotent stem cells; Cardiomyocyte; Heart-on-a-chip; Electrospun scaffolds; Biocompatible materials; PLURIPOTENT STEM-CELLS; ENGINEERED HEART-TISSUE; ORAL D-SOTALOL; CARDIAC TISSUE; ELECTRICAL-STIMULATION; MYOCARDIAL-INFARCTION; ENDOTHELIAL-CELLS; ELECTROPHYSIOLOGICAL MATURATION; MECHANICAL STIMULATION; CYCLIC STRAIN;
D O I
10.1016/j.molliq.2023.122668
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Cardiovascular diseases are the leading cause of death worldwide. Several strategies - small molecules, gene therapy, surgeries, cardiac rehabilitation - have been developed to treat patients with cardiac disorders or to prevent the disease. A novel promising tool is the application of induced pluripotent stem cell-derived human cardiomyocytes; however, their clinical application is hampered by their fundamentally immature characteristics. Although several approaches were recently proven to support certain aspects of cardiac maturation, it has been discovered that any kind of stimulus itself is insufficient to induce proper maturation of these cardiomyocytes. Therefore, researchers have developed multifactorial approaches linking biotechnology, life sciences and material sciences toolsets. In this review, we summarise the current state-of-the-art methodologies in cardiac differentiation and maturation with the application of biocompatible materials and automated cell culture systems combined with various electrical, mechanical, topological, and biochemical stimuli.
引用
收藏
页数:21
相关论文
共 50 条
  • [21] Impact of serum in the pharmacological response of human iPSC-derived cardiomyocytes
    Goineau, Sonia
    Legrand, Christophe
    Hunault, Marion
    Froget, Guillaume
    Castagne, Vincent
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2018, 93 : 163 - 163
  • [22] Contractility assessment using aligned human iPSC-derived cardiomyocytes
    Satsuka, Ayano
    Ribeiro, Alexandre J. S.
    Kawagishi, Hiroyuki
    Yanagida, Shota
    Hirata, Naoya
    Yoshinaga, Takashi
    Kurokawa, Junko
    Sugiyama, Atsushi
    Strauss, David G.
    Kanda, Yasunari
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2024, 128
  • [23] Characterization of Sarcolemmal KAtp Channels in Human Ipsc-derived Cardiomyocytes
    Geiger, Robert
    Fatima, Naheed
    Klein, Michael
    Goldstein, Robert E.
    Haigney, Mark C.
    Flagg, Thomas P.
    [J]. CIRCULATION, 2020, 142
  • [24] Space microgravity improves proliferation of human iPSC-derived cardiomyocytes
    Rampoldi, Antonio
    Forghani, Parvin
    Li, Dong
    Hwang, Hyun
    Armand, Lawrence Christian
    Fite, Jordan
    Boland, Gene
    Maxwell, Joshua
    Maher, Kevin
    Xu, Chunhui
    [J]. STEM CELL REPORTS, 2022, 17 (10): : 2272 - 2285
  • [25] Integrated electrophysiologic analyses of amiodarone in human iPSC-derived cardiomyocytes
    Bhagavan, Druv
    Moreno, Jonathan D.
    Kernik, Divya C.
    Guo, Jingxuan
    Huebsch, Nathaniel
    Silva, Jonathan R.
    [J]. BIOPHYSICAL JOURNAL, 2022, 121 (03) : 235A - 235A
  • [26] Structural and Electrophysiological Maturation of Human iPSC-Derived Atrial Cardiomyocytes to Serve as a Platform to Model Atrial Fibrillation
    Ly, Olivia T.
    Youn, Seock Won
    Brown, Grace
    Hong, Liang
    Sridhar, Arvind
    Zhang Meihong
    Lambers, Erin
    Khetani, Salman
    Darbar, Dawood
    [J]. CIRCULATION RESEARCH, 2019, 125
  • [27] High throughput chronic cardiotoxicity evaluation of human iPSC-derived cardiomyocytes in a pro-maturation environment
    Gossmann, M.
    Lickiss, B.
    Dragicevic, E.
    Linder, P.
    Thomas, U.
    Stoelzle-Feix, S.
    George, M.
    Fertig, N.
    [J]. TOXICOLOGY LETTERS, 2021, 350 : S224 - S224
  • [28] The effect of triiodothyronine hormone on human iPSC-derived cardiomyocyte maturation
    Kolker, L.
    Ali, N. N.
    Maclellan, K.
    Moore, M.
    Wheeler, J.
    Harding, S. E.
    Fleck, R. A.
    [J]. CARDIOVASCULAR RESEARCH, 2012, 93 : S58 - S58
  • [29] Characterization of cardiac metabolism in iPSC-derived cardiomyocytes: lessons from maturation and disease modeling
    Sofija Vučković
    Rafeeh Dinani
    Edgar E. Nollet
    Diederik W. D. Kuster
    Jan Willem Buikema
    Riekelt H. Houtkooper
    Miranda Nabben
    Jolanda van der Velden
    Birgit Goversen
    [J]. Stem Cell Research & Therapy, 13
  • [30] Characterization of cardiac metabolism in iPSC-derived cardiomyocytes: lessons from maturation and disease modeling
    Vuckovic, Sofija
    Dinani, Rafeeh
    Nollet, Edgar E.
    Kuster, Diederik W. D.
    Buikema, Jan Willem
    Houtkooper, Riekelt H.
    Nabben, Miranda
    van der Velden, Jolanda
    Goversen, Birgit
    [J]. STEM CELL RESEARCH & THERAPY, 2022, 13 (01)